$CEVA
CEVA INC Stock $ceva

$ceva Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923013600 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$26.17M	$28.74M
YoY Change	-21.16%	-16.45%
Cost Of Revenue	$5.572M	$5.315M
YoY Change	-18.36%	-17.0%
Gross Profit	$20.60M	$23.42M
YoY Change	-21.88%	-16.32%
Gross Profit Margin	78.71%	81.5%
Selling, General & Admin	$6.964M	$7.093M
YoY Change	9.53%	8.14%
% of Gross Profit	33.81%	30.29%
Research & Development	$19.59M	$20.79M
YoY Change	0.29%	2.87%
% of Gross Profit	95.12%	88.77%
Depreciation & Amortization	$1.422M	$742.0K
YoY Change	-28.25%	-4.87%
% of Gross Profit	6.9%	3.17%
Operating Expenses	$26.87M	$28.21M
YoY Change	0.86%	2.52%
Operating Profit	-$6.274M	-$4.793M
YoY Change	2173.19%	-1124.15%
Interest Expense	$1.002M	$1.338M
YoY Change	-468.38%	-257.6%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$5.272M	-$3.455M
YoY Change	862.04%	806.82%
Income Tax	$546.0K	$1.417M
% Of Pretax Income
Net Earnings	-$5.818M	-$4.872M
YoY Change	418.08%	187.26%
Net Earnings / Revenue	-22.23%	-16.95%
Basic Earnings Per Share	-$0.25	-$0.21
Diluted Earnings Per Share	-$0.25	-$0.21
COMMON SHARES
Basic Shares Outstanding	23.42M	23.42M
Diluted Shares Outstanding	23.48M	23.33M

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$125.2M	$130.6M
YoY Change	-9.3%	-1.34%
Cash & Equivalents	$27.51M	$24.48M
Short-Term Investments	$97.70M	$106.1M
Other Short-Term Assets	$7.753M	$8.766M
YoY Change	2.53%	-23.25%
Inventory
Prepaid Expenses
Receivables	$31.87M	$35.01M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$175.3M	$180.6M
YoY Change	0.98%	-8.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.868M	$6.696M
YoY Change	-55.34%	-14.61%
Goodwill	$76.77M	$74.78M
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments	$172.0K	$8.571M
YoY Change	-98.12%	379.36%
Other Assets	$7.595M	$6.874M
YoY Change	-77.83%	72.97%
Total Long-Term Assets	$125.0M	$130.6M
YoY Change	-14.29%	-5.2%
TOTAL ASSETS
Total Short-Term Assets	$175.3M	$180.6M
Total Long-Term Assets	$125.0M	$130.6M
Total Assets	$300.3M	$311.1M
YoY Change	-5.99%	-7.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.104M	$1.820M
YoY Change	-50.74%	-42.7%
Accrued Expenses	$5.563M	$7.280M
YoY Change	-77.57%	76.4%
Deferred Revenue	$3.788M	$4.006M
YoY Change		-54.12%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$26.13M	$35.04M
YoY Change	-17.29%	-14.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$15.56M	$16.23M
YoY Change	10.35%	0.33%
Total Long-Term Liabilities	$15.56M	$16.23M
YoY Change	10.35%	0.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.13M	$35.04M
Total Long-Term Liabilities	$15.56M	$16.23M
Total Liabilities	$41.69M	$51.26M
YoY Change	-8.76%	-10.0%
SHAREHOLDERS EQUITY
Retained Earnings	$21.36M	$27.29M
YoY Change		-49.24%
Common Stock	$244.3M	$243.2M
YoY Change		3.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$258.6M	$259.9M
YoY Change
Total Liabilities & Shareholders Equity	$300.3M	$311.1M
YoY Change	-5.99%	-7.14%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$5.818M	-$4.872M
YoY Change	418.08%	187.26%
Depreciation, Depletion And Amortization	$1.422M	$742.0K
YoY Change	-28.25%	-4.87%
Cash From Operating Activities	-$4.787M	-$5.076M
YoY Change	-41.0%	-151.67%
INVESTING ACTIVITIES
Capital Expenditures	$1.126M	$105.0K
YoY Change	-194.3%	-88.45%
Acquisitions
YoY Change
Other Investing Activities	$8.959M	$6.645M
YoY Change	-243.37%	-270.21%
Cash From Investing Activities	$7.833M	$6.540M
YoY Change	-205.24%	-235.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$1.673M
YoY Change	-100.0%	-2.73%
NET CHANGE
Cash From Operating Activities	-4.787M	-$5.076M
Cash From Investing Activities	7.833M	$6.540M
Cash From Financing Activities	0.000	$1.673M
Net Change In Cash	3.046M	$3.198M
YoY Change	-115.22%	-51.73%
FREE CASH FLOW
Cash From Operating Activities	-$4.787M	-$5.076M
Capital Expenditures	$1.126M	$105.0K
Free Cash Flow	-$5.913M	-$5.181M
YoY Change	-14.54%	-158.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	ceva	Accrued Severance Pay Noncurrent AccruedSeverancePayNoncurrent	9064000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6530000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6703000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	633000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	526000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	16227000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	16293000	usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	313000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	313000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23595160
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23595160
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23416026
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23215439
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	179134
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	379721
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriod	0
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-49842
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0556376
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	15245 Shady Grove Road, Suite 400
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Rockville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20850
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20850
CY2023Q1	dei	City Area Code CityAreaCode	240
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	308-8328
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $.001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	CEVA
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23416026
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24483000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21285000	usd
CY2023Q1	ceva	Shortterm Bank Deposits ShorttermBankDeposits	6164000	usd
CY2022Q4	ceva	Shortterm Bank Deposits ShorttermBankDeposits	6114000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	106142000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	112080000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35007000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31250000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8766000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6896000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	180562000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	177625000	usd
CY2023Q1	ceva	Longterm Bank Deposits LongtermBankDeposits	8280000	usd
CY2022Q4	ceva	Longterm Bank Deposits LongtermBankDeposits	8205000	usd
CY2023Q1	ceva	Severance Pay Fund Noncurrent SeverancePayFundNoncurrent	8183000	usd
CY2022Q4	ceva	Severance Pay Fund Noncurrent SeverancePayFundNoncurrent	8475000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9434000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8599000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6696000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7099000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10034000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10283000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	74777000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	74777000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6003000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6680000	usd
CY2023Q1	us-gaap	Other Long Term Investments OtherLongTermInvestments	291000	usd
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	408000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6874000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6291000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	130572000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	130817000	usd
CY2023Q1	us-gaap	Assets Assets	311134000	usd
CY2022Q4	us-gaap	Assets Assets	308442000	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1820000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1995000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4006000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3168000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7280000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6660000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	19073000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18473000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2858000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2982000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	35037000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	33278000	usd
CY2023Q1	ceva	Accrued Severance Pay Noncurrent AccruedSeverancePayNoncurrent	9064000	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	243141000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	242841000	usd
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	4672000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	9904000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5910000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6249000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	27288000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	32160000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	259870000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	258871000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	311134000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	308442000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	28735000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	34391000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	5315000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	6404000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	23420000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	27987000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20791000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20210000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3045000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2923000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4048000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3636000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	329000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	750000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	28213000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	27519000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4793000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	468000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	1455000	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	282000	usd
CY2023Q1	ceva	Remeasurement Of Marketable Equity Securities RemeasurementOfMarketableEquitySecurities	117000	usd
CY2022Q1	ceva	Remeasurement Of Marketable Equity Securities RemeasurementOfMarketableEquitySecurities	1131000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3455000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-381000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1417000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1315000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4872000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1696000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23334000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23103000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23334000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23103000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4872000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1696000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	730000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-2839000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	92000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	638000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-2839000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-425000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	2000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-171000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-110000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax	-254000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax	112000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	384000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-2727000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	45000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-661000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	339000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2066000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4533000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3762000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	258871000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4872000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	339000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3859000	usd
CY2023Q1	ceva	Treasury Stock Issued During Period Value Stock Options Exercised TreasuryStockIssuedDuringPeriodValueStockOptionsExercised	1673000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	259870000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	276732000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1696000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2066000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3389000	usd
CY2022Q1	ceva	Treasury Stock Issued During Period Value Stock Options Exercised TreasuryStockIssuedDuringPeriodValueStockOptionsExercised	1720000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	278079000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4872000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1696000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	742000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	780000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	677000	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1167000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3859000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3389000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	92000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-0	usd
CY2023Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	23000	usd
CY2022Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	123000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	285000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-154000	usd
CY2023Q1	ceva	Remeasurement Of Marketable Equity Securities RemeasurementOfMarketableEquitySecurities	117000	usd
CY2022Q1	ceva	Remeasurement Of Marketable Equity Securities RemeasurementOfMarketableEquitySecurities	1131000	usd
CY2023Q1	ceva	Increase Decrease In Accounts Receivable And Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndUnbilledReceivables	3802000	usd
CY2022Q1	ceva	Increase Decrease In Accounts Receivable And Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndUnbilledReceivables	-3944000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2205000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3034000	usd
CY2023Q1	ceva	Changes In Operating Assets And Liabilities Operating Lease Right Of Use Assets ChangesInOperatingAssetsAndLiabilitiesOperatingLeaseRightOfUseAssets	249000	usd
CY2022Q1	ceva	Changes In Operating Assets And Liabilities Operating Lease Right Of Use Assets ChangesInOperatingAssetsAndLiabilitiesOperatingLeaseRightOfUseAssets	425000	usd
CY2023Q1	ceva	Increase Decrease In Accrued Interest On Bank Deposits IncreaseDecreaseInAccruedInterestOnBankDeposits	125000	usd
CY2022Q1	ceva	Increase Decrease In Accrued Interest On Bank Deposits IncreaseDecreaseInAccruedInterestOnBankDeposits	9000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	880000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	991000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-412000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	736000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	838000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	70000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	357000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	92000	usd
CY2023Q1	ceva	Increase Decrease In Accrued Salaries And Related Expenses IncreaseDecreaseInAccruedSalariesAndRelatedExpenses	-702000	usd
CY2022Q1	ceva	Increase Decrease In Accrued Salaries And Related Expenses IncreaseDecreaseInAccruedSalariesAndRelatedExpenses	-3710000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-275000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-454000	usd
CY2023Q1	ceva	Increase Decrease In Accrued Severance Pay Net IncreaseDecreaseInAccruedSeverancePayNet	308000	usd
CY2022Q1	ceva	Increase Decrease In Accrued Severance Pay Net IncreaseDecreaseInAccruedSeverancePayNet	287000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5076000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9824000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	105000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	909000	usd
CY2023Q1	ceva	Proceeds From Bank Deposits ProceedsFromBankDeposits	0	usd
CY2022Q1	ceva	Proceeds From Bank Deposits ProceedsFromBankDeposits	1385000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	8789000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1750000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3500000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	4895000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6540000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4813000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1673000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1720000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1673000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1720000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-106000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3198000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6625000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21285000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	33153000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24483000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39778000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1860000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2355000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	234000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	948000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	506000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	308000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> <p style="margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><b>NOTE <em style="font: inherit;">1:</em></b></p> </td><td style="width: auto;"> <p style="margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><b>BUSINESS </b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The financial information in this quarterly report includes the results of CEVA, Inc. and its subsidiaries (the “Company” or “CEVA”).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">CEVA licenses a family of wireless connectivity and smart sensing technologies and is a provider of chip design services. The Company’s offerings include Digital Signal Processors (“DSPs”), AI processors, short and long range connectivity solutions, <em style="font: inherit;">5G</em> wireless platforms and complementary software for sensor fusion, spatial audio, image enhancement, computer vision, voice input and artificial intelligence, all of which are key enabling technologies for a smarter, more connected world. These technologies are offered in combination with Non-Recurring Engineering (“NRE”) services from CEVA’s Intrinsix Corp. (“Intrinsix”) business, helping customers address their most complex and time-critical integrated circuit design projects. CEVA’s DSP-based solutions address the technology requirements of: <em style="font: inherit;">5G</em> baseband processing for mobile, broadband, cellular IoT and Radio Access Network (“RAN”); computer vision for any camera, <em style="font: inherit;">4D</em> and LIDAR-enabled device; audio/voice/sound; and ultra-low-power always-on/sensing applications for wearables, hearables and multiple IoT markets. For motion sensors and sensor fusion, CEVA’s Hillcrest Labs sensor processing technologies provide a broad range of software and Inertial Measurement Unit (“IMU”) solutions for markets including hearables, wearables, AR/VR, PC, robotics, remote controls and IoT. For wireless IoT, the Rivierawaves platforms for Bluetooth (low energy and dual mode), Wi-Fi <em style="font: inherit;">4/5/6/6E</em> (<em style="font: inherit;">802.11n/ac/ax</em>), Ultra-WideBand (“UWB”) are the most broadly licensed connectivity platforms in the industry.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">CEVA’s Intrinsix business also expands its market reach to the aerospace and defense markets and allows it to offer co-creation solutions that combine CEVA’s standardized, off-the-shelf IP together with Intrinsix’s NRE design capabilities and IP in RF, mixed-signal, security, high complexity digital design, chiplets and more.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">CEVA’s technologies are licensed to leading semiconductor and Original Equipment Manufacturer (“OEM”) companies. These companies design, manufacture, market and sell Application-Specific Integrated Circuits (“ASICs”) and Application-Specific Standard Products (“ASSPs”) based on CEVA’s technology to mobile, consumer, automotive, robotics, industrial, aerospace & defense and IoT companies for incorporation into a wide variety of end products.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Use of Estimates </i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	10083000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	906000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	519000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	96000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	28735000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	34391000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	28735000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	34391000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	28735000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	34391000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1561000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0351	pure
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	822000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	800000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	819000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	830000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2257000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2589000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1979000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	970000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	962000	usd
CY2023Q1	ceva	Lessee Operating Lease Liability To Be Paid Year Five And Thereafter LesseeOperatingLeaseLiabilityToBePaidYearFiveAndThereafter	1361000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10118000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	730000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	9388000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	36115000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	877000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	64211000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	5337000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	58706000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1885000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	48539000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4980000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	92000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	-0	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	-0	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	291000	usd
CY2023Q1	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	360000	usd
CY2022Q4	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure	13000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	408000	usd
CY2022Q4	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	119000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	22661000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13102000	usd
CY2023Q1	ceva	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	3556000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6003000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	22661000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12425000	usd
CY2022Q4	ceva	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	3556000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6680000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1934000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1909000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1189000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	956000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	15000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6003000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	28735000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	34391000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4872000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1696000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23334000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23103000
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23334000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23103000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1181119
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	853258
CY2022Q4	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber	106000
CY2022Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weightedaverage Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedaverageExercisePrice	20.24
CY2022	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm	P2Y
CY2022Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsAggregateIntrinsicValueOutstanding	609000	usd
CY2023Q1	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber	106000
CY2023Q1	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weightedaverage Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedaverageExercisePrice	20.24
CY2023Q1	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm	P1Y9M18D
CY2023Q1	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsAggregateIntrinsicValueOutstanding	1080000	usd
CY2023Q1	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercisable Number SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisableNumber	106000
CY2023Q1	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableWeightedAverageExercisePrice	20.24
CY2023Q1	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Execisable Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExecisableWeightedAverageRemainingContractualTerms	P1Y9M18D
CY2023Q1	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Aggregate Intrinsic Value Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsAggregateIntrinsicValueExercisable	1080000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3859000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3389000	usd
CY2023Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	9700000	usd
CY2022Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	12200000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	171000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	110000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	278799

Files In Submission

Name	View Source	Status
ceva-20230331_cal.xml	Edgar Link	unprocessable
ceva-20230331_pre.xml	Edgar Link	unprocessable
0001437749-23-013600-index-headers.html	Edgar Link	pending
0001437749-23-013600-index.html	Edgar Link	pending
0001437749-23-013600.txt	Edgar Link	pending
0001437749-23-013600-xbrl.zip	Edgar Link	pending
ceva-20230331.xsd	Edgar Link	pending
ceva20230331_10q.htm	Edgar Link	pending
ex_515346.htm	Edgar Link	pending
ex_515347.htm	Edgar Link	pending
ex_515348.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
ceva-20230331_def.xml	Edgar Link	unprocessable
ceva-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ceva20230331_10q_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CEVA
CEVA INC Stock $ceva

2023 Q2 Form 10-Q Financial Statement

#000143774923013600 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEVA CEVA INC Stock $ceva

2023 Q2 Form 10-Q Financial Statement

#000143774923013600 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEVA
CEVA INC Stock $ceva